Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lili Zhi

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Cell Death and Differentiation|May 10, 2022
Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancerJinrui Zhang, Ge Zhang, Wenjing Zhang, et al.
The Journal of Clinical Investigation|October 5, 2021
RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11Wenjing Zhang, Yu Sun, Lu Bai, et al.
JMIR Public Health and Surveillance|October 16, 2024
Protective Effect of Allergen Immunotherapy in Patients With Allergic Rhinitis and Asthma Against COVID-19 Infection: Observational, Nationwide, and Multicenter StudyRundong Qin, Yan Feng, Huanping Zhang, et al.
Medcomm|June 8, 2026
Trends in Asthma-Rhinitis Allergic Multimorbidity and Polysensitization in China: The CARRAD StudyWanjun Wang, Jianhong Wang, Guihua Song, et al.
Clinical and Translational Allergy|February 9, 2022
Environmental and sensitization variations among asthma and/or rhinitis patients between 2008 and 2018 in ChinaWanjun Wang, Jianhong Wang, Guihua Song, et al.
The World Allergy Organization Journal|December 22, 2021
Expert consensus on the use of omalizumab in chronic urticaria in ChinaZuotao Zhao, Tao Cai, Hong Chen, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Cell Death and Differentiation|May 10, 2022
Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancerJinrui Zhang, Ge Zhang, Wenjing Zhang, et al.
The Journal of Clinical Investigation|October 5, 2021
RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11Wenjing Zhang, Yu Sun, Lu Bai, et al.
JMIR Public Health and Surveillance|October 16, 2024
Protective Effect of Allergen Immunotherapy in Patients With Allergic Rhinitis and Asthma Against COVID-19 Infection: Observational, Nationwide, and Multicenter StudyRundong Qin, Yan Feng, Huanping Zhang, et al.
Medcomm|June 8, 2026
Trends in Asthma-Rhinitis Allergic Multimorbidity and Polysensitization in China: The CARRAD StudyWanjun Wang, Jianhong Wang, Guihua Song, et al.
Clinical and Translational Allergy|February 9, 2022
Environmental and sensitization variations among asthma and/or rhinitis patients between 2008 and 2018 in ChinaWanjun Wang, Jianhong Wang, Guihua Song, et al.
The World Allergy Organization Journal|December 22, 2021
Expert consensus on the use of omalizumab in chronic urticaria in ChinaZuotao Zhao, Tao Cai, Hong Chen, et al.
Pageof 4